top of page
PIPELINE
We are advancing a robust pipeline of Supercharged Cell therapies powered by our proprietary cell enhancements
Product
Therapy
Target / Indications
CIB-301
In vivo CAR-T
Cellinfinity's novel target & enhancements for solid tumors
CIB-201
Autologous CAR-T
Cellinfinity's novel target & enhancements for solid tumors
Discovery
Lead Optimization
IND-enabling
Cellinfinity has multiple pre-clinical candidates available for collaborations.
bottom of page